Parents Ask
Is Red Light Therapy Safe for Children's Eyes? What the Trials Actually Show
Repeated low-level red-light (RLRL) therapy is one of the strongest myopia-control tools studied — and the one parents ask about most nervously. Fair question. Here is the honest answer.
What the evidence says
The pivotal evidence comes from randomized controlled trials in China using desktop 650-nm devices, typically twice a day, three minutes per session, five days a week:
- Efficacy. The multicenter RCT by Jiang and colleagues (264 children, 12 months) found axial elongation of 0.13 mm in the red-light group versus 0.38 mm with glasses alone, and myopia progression of −0.20 D versus −0.79 D — roughly a two-thirds reduction. No severe adverse events, no loss of visual acuity, and no structural retinal damage on OCT were observed.
- Two-year follow-up. Xiong and colleagues followed children for a second year: the effect was sustained with continued use, still without serious side effects. A modest rebound appeared in children who stopped — which is an argument for monitoring, not against the therapy.
- Retinal function testing. A 2024 trial (Zhu and colleagues, 108 children) measured retinal electrical responses (mfERG), contrast sensitivity and OCT layer reflectance over 12 months and found no safety signal — while noting that two OCT reflectance measures rose slightly, a finding the authors say needs continued observation.
The part responsible sources agree on: monitoring is not optional
In 2025, a randomized trial reported in JAMA Ophthalmology documented three children (out of the red-light arm) who developed a small, transient change visible only on OCT — a spot of heightened reflectivity near the fovea — which resolved on its own within half a month to three months after stopping, with no loss of visual acuity. An earlier single case report described a child with retinal changes and vision loss that recovered after cessation.
These are exactly the kinds of findings that routine scans exist to catch early. The takeaway is not "red light is dangerous" — the trials overall show a reassuring profile — it is that any family using red light should do so under an eye-care professional, with a baseline OCT and periodic follow-up scans, and stop and reassess if anything changes.
Who should not use it, and what to ask before starting
Trials typically exclude children with retinal disease, optic nerve conditions, a family history of certain retinal disorders, or photosensitizing medication. Before starting, ask the prescribing professional four questions:
- Will my child get a baseline OCT and fundus photo — and how often are follow-up scans scheduled?
- What exact device, wavelength and dose schedule are you prescribing, and is it a licensed device in this country?
- What changes on a scan or in vision would make us pause or stop?
- How does this fit with the rest of the plan — outdoor time, defocus optics, and axial-length tracking every 3 months?
Red light is one layer of the 6S Method — never a substitute for the two layers that cost nothing: two hours outdoors a day and healthy near-work habits. Devices come and go; the tracking habit is what protects your child through all of them.
Whatever therapy you choose, the scan schedule is what keeps it safe.
Log every axial-length measurement and OCT date in one place, and see the trend before anyone guesses.
Evidence base for this page (red-light evidence and safety monitoring): #22 · #23 · #24 · #28 · #91 — full citations and DOI links in our Evidence Library.